Correlation between serum 25(OH)D values and lupus disease activity: An original article and a systematic review with meta-analysis focusing on serum VitD confounders

Lupus

Volumn 23, Issue 11, 2014, Pages 1164-1177

  Sahebari, M ^a   Nabavi, N ^a   Salehi, M ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

25(OH)D; Lupus; Meta analysis; Original article; SLE; SLEDAI; Systematic review; Systemic lupus erythematosus; Vitamin D; VitD

Indexed keywords

25 HYDROXYVITAMIN D; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DNA ANTIBODY; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROTEIN; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEINURIA; SLEDAI; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; COMPLICATION; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROSPECTIVE STUDIES; PROTEINURIA; SEVERITY OF ILLNESS INDEX; VITAMIN D; YOUNG ADULT;

EID: 84925641877     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314540966     Document Type: Article

References (65)

1. Müller K, Kriegbaum N, Baslund B, Sørensen O, Thymann M, Bentzen K. Vitamin D3 metabolism in patients with rheumatic diseases: Low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995; 14: 397-400.
2. Thomasset M. Vitamin D and the immune system [article in French]. Pathol Biol (Paris) 1994; 42: 163-172.
3. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 2012; 76: 315-325.
4. Munoz LE, Schiller M, Zhao Y, Voll RE, Schett G, Herrmann M. Do low vitamin D levels cause problems of waste removal in patients with SLE? Rheumatology (Oxford) 2012; 51: 585-587.
5. Becker A, Fischer R, Schneider M. Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus [article in German]. Z Rheumatol 2001; 60: 352-358.
6. Marques CD, Dantas AT, Fragoso TS, Duarte ÂL. The importance of vitamin D levels in autoimmune diseases. Rev Bras Reumatol 2010; 50: 67-80.
7. Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E. The immunopathological role of vitamin D in patients with SLE: Data from a single centre registry in Hungary. Scand J Rheumatol 2011; 40: 122-126.
8. Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A. Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 2011; 20: 1155-1160.
9. Ben-Zvi I, Aranow C, Mackay M, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010; 5: e9193.
10. Wu PW, Rhew EY, Dyer AR, et al. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 1387-1395.
11. Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, et al. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 2012; 21: 477-484.
12. Costenbader KH, Feskanich D, Holmes M, Karlson E, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67: 530-535.
13. Birmingham DJ, Hebert LA, Song H, et al. Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 2012; 21: 855-864.
14. López-Robles C, Rios-Fernández R, Callejas-Rubio J, Ortego-Centeno N. Vitamin D deficiency in a cohort of patients with systemic lupus erythematous from the South of Spain. Lupus 2011; 20: 330-331.
15. Monticielo O, Brenol J, Chies J, et al. The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 2012; 21: 43-52.
16. Word A, Perese F, Tseng LC, Adams-Huet B, Olsen N, Chong B. 25-Hydroxyvitamin D levels in African-American and Caucasian/Hispanic subjects with cutaneous lupus. Br J Dermatol 2012; 166: 372-379.
17. Sakthiswary R, Raymond AA. The clinical significance of vitamin D in systemic lupus erythematosus: A systematic review. PLoS One 2013; 8: e55275.
18. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE. Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179: 1634-1647.
19. Muñoz-Ortego J, Torrente-Segarra V, Prieto-Alhambra D, Salman-Monte T, Carbonell-Abello J. Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: A cohort study. Scand J Rheumatol 2012; 41: 472-475.
20. Aghdassi E, Morrison S, Landolt-Marticorena C, et al. The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus. J Rheumatol 2010; 37: 87-90.
21. Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25- OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69: 1155-1157.
22. Breslin LC, Magee PJ, Wallace JM, McSorley EM. An evaluation of vitamin D status in individuals with systemic lupus erythematosus. Proc Nutr Soc 2011; 70: 399-407.
23. Fragoso TS, Dantas AT, Marques CD, et al. 25-Hydroxyivitamin [sic] D3 levels in patients with systemic lupus erythematosus and its association with clinical parameters and laboratory tests [article in English and Portuguese]. Rev Bras Reumatol 2012; 52: 60-65.
24. Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008; 20: 532-537.
25. Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: A comparison with anti-dsDNA and anti-C1q. Lupus 2012; 21: 36-42.
26. Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH. Vitamin D levels in Chinese patients with systemic lupus erythematosus: Relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) 2012; 51: 644-652.
27. Souto M, Coelho A, Guo C, et al. Vitamin D insufficiency in Brazilian patients with SLE: Prevalence, associated factors, and relationship with activity. Lupus 2011; 20: 1019-1026.
28. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2008; 47: 920-923.
29. Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken) 2010; 62: 1160-1165.
30. Orbach H, Zandman-Goddard G, Amital H, et al. Novel biomarkers in autoimmune diseases. Ann N Y Acad Sci 2007; 1109: 385-400.
31. Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: A randomized placebo-controlled trial. J Rheumatol 2013; 40: 265-272.
32. Terrier B, Derian N, Schoindre Y, et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther 2012; 14: R221.
33. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
34. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
35. Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009; 155: 260-265.
36. Bombardier C, Gladman D, Urowitz MB, Caron D, Chang C. Derivation of the SLEDAI: A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
37. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
38. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 114-117.
39. Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, et al. Requirement of vitamin D supplementation in patients with systemic lupus erythematosus. Reumatologia 2008; 46: 223-229.
40. Thudi A, Yin S, Wandstrat AE, Li QZ, Olsen NJ. Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci 2008; 335: 99-104.
41. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009; 20: 427-433.
42. Toloza S, Cole D, Gladman D, Ibañez D, Urowitz M. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010; 19: 13-19.
43. Hamza RT, Awwad KS, Ali MK, Hamed AI. Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: Relation to disease activity. Med Sci Monit 2011; 17: CR711-CR718.
44. Kim HA, Sung JM, Jeon JY, Yoon JM, Suh CH. Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol Int 2011; 31: 1189-1194.
45. Ezzat Y, Sayed S, Gaber W, Mohey AM, Kassem TW. 25- Hydroxy vitamin D levels and its relation to disease activity and cardiovascular risk factors in women with systemic lupus erythematosus. The Egyptian Rheumatologist 2011; 33: 195-201.
46. Yeap SS, Othman AZ, Zain AA, Chan SP. Vitamin D levels: Its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids. Int J Rheum Dis 2012; 15: 17-24.
47. Robinson AB, Thierry-Palmer M, Gibson KL, Rabinovich CE. Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis. J Pediatr 2012; 160: 297-302.
48. Casella C, Seguro L, Takayama L, Medeiros D, Bonfa E, Pereira R. Juvenile onset systemic lupus erythematosus: A possible role for vitamin D in disease status and bone health. Lupus 2012; 21: 1335-1342.
49. Reynolds JA, Haque S, Berry JL, et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology 2012; 51: 544-551.
50. Sumethkul K, Boonyaratavej S, Kitumnuaypong T, et al. The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int 2013; 33: 1461-1467.
51. Attar SM, Siddiqui AM. Vitamin D deficiency in patients with systemic lupus erythematosus. Oman Med J 2013; 28: 42-47.
52. Chaiamnuay S, Chailurkit LO, Narongroeknawin P, Asavatanabodee P, Laohajaroensombat S, Chaiamnuay P. Current daily glucocorticoid use and serum creatinine levels are associated with lower 25 (OH) vitamin D levels in Thai patients with systemic lupus erythematosus. J Clin Rheumatol 2013; 19: 121-125.
53. Hewison M. Vitamin D and the immune system: New perspectives on an old theme. Endocrinol Metab Clin North Am 2010; 39: 365-379, table of contents.
54. Abbasi M, Rezaieyazdi Z, Afshari JT, Hatef M, Sahebari M, Saadati N. Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus. Rheumatol Int 2010; 30: 1537-1539.
55. Vogeser M. Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry. J Steroid Biochemistry Mol Biol 2010; 121: 565-573.
56. Janssen MJ, Wielders JP, Bekker CC, et al. Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum. Steroids 2012; 77: 1366-1372.
57. Andress D. Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation. Kidney Int 2006; 69: 33-43.
58. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: A systematic review. Ann Rheum Dis 2010; 69: 20-28.
59. Barnes T, Bucknall R. Vitamin D deficiency in a patient with systemic lupus erythematosus. Rheumatology 2004; 43: 393-394.
60. Sharma OP. Hypercalcemia in granulomatous disorders: A clinical review. Curr Opin Pulm Med 2000; 6: 442-447.
61. Stockton K, Mengersen K, Paratz J, Kandiah D, Bennell K. Effect of vitamin D supplementation on muscle strength: A systematic review and meta-analysis. Osteoporos Int 2011; 22: 859-871.
62. Breslin L, Duffy EM, Mulholland H, et al. Vitamin D status and disease activity in systemic lupus erythematosus in Northern Ireland. Proc Nutr Soc 2009; 68(OCE): E113.
63. Damanhouri LH. Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J 2009; 30: 1291-1295.
64. Dö rr J, Ohlraun S, Skarabis H, Paul F. Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): Study protocol for a randomized controlled trial. Trials 2012; 13: 15.
65. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women. JAMA 2010; 303: 1815-1822.